Medtronic plc — Director's Dealing 2018

Mar 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-03-13

Reporting Person: Lenehan James T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-13	Ordinary Shares	M	1590	$50.34	Acquired	48334	Direct
2018-03-13	Ordinary Shares	S	1306	$83.555	Disposed	47028	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-13	Stock Option (Right to Buy)	$50.34	M	1590	Disposed	2018-04-28	Ordinary Shares (1590)	Direct

Footnotes

F1: This balance increased 391 shares due to exempt transactions such as dividend reinvestment.

F2: This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.